Drug Insights

A Complete Guide to Searching Phenylephrine on Synapse

29 February 2024
2 min read

Phenylephrine, a minuscule molecule drug, exhibits its alpha-1 adrenergic receptor agonist activity, thereby aiding in the dilation of the pupil during ophthalmic exams and procedures. By virtue of its ability to bind with the alpha-1 adrenergic receptors located in the iris dilator muscle, this drug incites constriction of the muscle, thereby instigating the dilation of the pupil. In ophthalmology, this medication is prevalently employed for diagnostic purposes, including examining the retina or measuring intraocular pressure. Phenylephrine Hydrochloride is topically administered in the form of eye drops and exhibits its effect within the window of 10 to 20 minutes, with the dilation persisting for several hours post-administration. Click on the image below to begin the exploration journey of Phenylephrine through the Synapse database!

图形用户界面, 应用程序

描述已自动生成

You can search for the latest pharmaceutical information such as drugs, targets, patents, transactions, clinical results, etc. through the Synapse database. Come and experience it!

图形用户界面, 文本, 应用程序, 聊天或短信

描述已自动生成

Oscotec/Adel Begins Phase 1 Trial of ADEL-Y01 Anti-Tau Antibody for Alzheimer's
Latest Hotspot
3 min read
Oscotec/Adel Begins Phase 1 Trial of ADEL-Y01 Anti-Tau Antibody for Alzheimer's
29 February 2024
Oscotec/Adel has commenced the initial human administration phase of their Phase 1 trial, testing the anti-tau antibody ADEL-Y01 as a potential treatment for Alzheimer's.
Read →
Erdafitinib: A Quick Look at Its R&D Progress and Clinical Results from the 2024 ASCO_GU
Erdafitinib: A Quick Look at Its R&D Progress and Clinical Results from the 2024 ASCO_GU
29 February 2024
TAR-210 is an intravesical drug delivery system that is designed to provide local, continuous release of erdafitinib.
Read →
U.S. and China Approve INDs for New EpCAM CAR-T Therapy Against Solid Tumors
Latest Hotspot
3 min read
U.S. and China Approve INDs for New EpCAM CAR-T Therapy Against Solid Tumors
29 February 2024
Immunofoco Reveals U.S. and China Regulators Grant Green Light to IND Submissions for Novel EpCAM CAR-T Therapy Aimed at Treating Severe Solid Cancers.
Read →
Using Synapse for Your Metoclopramide Research: An Easy Guide
Drug Insights
2 min read
Using Synapse for Your Metoclopramide Research: An Easy Guide
29 February 2024
Metoclopramide, marketed under the brand name REGLAN®, is a small molecule drug that acts as a dopamine-2 (D2) antagonist.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.